Company Announcements

Quarterly Results And Dividend Announcement

Source: RNS
RNS Number : 6312K
CT Private Equity Trust PLC
29 May 2025
 

 

To: Stock Exchange

For immediate release:


29 May 2025

 

CT Private Equity Trust PLC

Quarterly results for the three months ended 31 March 2025 (unaudited)
 

·      Net asset value of 693.40 pence per share as at 31 March 2025.

·      A net asset value total return for the three-month period of -0.8%.

·      Quarterly dividend of 7.01 pence per Ordinary Share payable on 31 July 2025.

·      Dividend yield of 6.1% based on the period end share price.

 

 

∞ Calculated as dividends of 7.01 pence paid on 31 October 2024, 7.01 pence paid on 31 January 2025, 7.01 pence paid on 30 April 2025 and 7.01 pence payable on 31 July 2025 divided by the Company's share price of 459.00 pence as at 31 March 2025.

 

 

Manager's Review

 

Introduction

As at 31 March 2025 the net assets of the Company were £495.8 million giving a Net Asset Value per share of 693.40 pence which, taking account of the dividend of 7.01 pence paid on 31 January 2025, gives a total return for the quarter of -0.8%. This valuation is largely based on 31 December 2024 marks with only 3.5% of 31 March 2025 valuations included.

The share price total return for the quarter was -4.6%. The discount to NAV at quarter end was 33.8%, narrowing slightly to 30.9% at the time of writing.

At 31 March 2025 the Company had net debt of £90.4 million. The outstanding undrawn commitments were £182.4 million of which £28.7 million is to funds where the investment period has expired.

A dividend of 7.01 pence was paid on 30 April 2025. In accordance with the Company's dividend policy the next dividend will be 7.01 pence which will be paid on 31 July 2025 to shareholders on the register on 4 July 2025 with an ex-dividend date of 3 July 2025.

 

New Investments

Only one new investment was made in the quarter.

€2.1 million was invested in the Finnish IT services company Frendy. This is a co-investment alongside Procuritas, the long-established Nordic mid-market specialist. Frendy was formed by Procuritas in 2021 through the amalgamation of 10 companies with the aim of consolidating the fragmented IT services market in Finland. The original investment thesis has taken longer than expected and an opportunity arose for us to invest below the original entry price. Growth is now coming through driven by the transition to the cloud and strong demand for cyber-security. More companies have been added to the group and a growing proportion of revenues are on a recurring subscription basis. This is expected to be a shorter hold. CT Private Equity Trust holds 6.7% of the business.

The funds in the portfolio have added a number of interesting investments during the quarter. Software experts Axiom have called £1.8 million for Project Enola, a UK based investigation management and intelligence platform whose cloud based software is used by governments, police and investigation teams within corporates. SEP VI has called £1.4 million for two companies; Springtime, an Austrian accounts payable software company and Restrata a UK based critical event and business resilience software provider. Following the ubiquitous software theme, Volpi III has called £1.2 million for two companies; Bluestar, a Danish product life cycle software company and Telematrix, an Austrian provider of software for public transport. Verdane Edda invested £0.8 million across two platforms: Eversports a DACH focused software and sports facilities bookings platform; and Corlytics a regulatory intelligence and policy management software for financial services institutions and other regulated industries. In the consumer sector Piper Private Equity have called £0.6 million for Yard Sale Pizza, a chain of 14 shops in London which also delivers by e-bike and partners with 160 pubs and bars across London. The plan is to roll out the brand across London and other cities.

In North America Level 5 Fund II and Purpose Brands called £0.8 million for medical spa company Heyday. The company has 39 shops providing services such as dermaplaning and laser facials. TorQuest VI called £1.0 million for its first two investments; Mevotech is involved in the engineering, design and distribution of driveline, steering and suspension parts for the auto aftermarket; Athos is a funerary services company based in Quebec which is aiming to consolidate the fragmented Canadian market.

The total invested in new companies by way of co-investment and funds in the quarter was £15.7 million which was up 16% on Q4 2024 but down by 33% compared with the first quarter of 2024.

 

Realisations

Although the private equity market slowed somewhat as we entered 2025, there were a number of diverse exits or partial exits across the portfolio.

The largest inflow was of £3.1 million from our co-investment in electrical components company Sigma which has been recapitalised with a partial return to investors. The company had been in a sale process, but this will likely be paused as the impact of potential tariffs is assessed. So far, the additional costs have successfully been passed through to customers via price rises, however the longer term impact on demand in the company's end markets may take time to become clear.

Blue Point III returned £1.2 million (6.9x cost and 32% IRR) with the sale of industrial services contractor Sylvan, which provides design, installation and maintenance of industrial projects for clients in a range of sectors across North America. This company was held for seven years and built profits through derisking the supply chain by strategic acquisitions. Interestingly it was bought and sold for around 4.0x EBITDA.

Primary IV returned £1.1 million (3.6x cost and 21% IRR) with the sale of speciality signage company Metamark. MVM VI returned £1.1 million (4.0x cost and 216% IRR) from Gynesonics the developer of a minimally invasive medical device, Sonata, which is used for the treatment of uterine fibroids. Following a short hold of just 15 months the company was sold to Nasdaq listed Hologic. Vaaka III returned £0.9 million through a recapitalisation of Framery, the Finland based provider of sound proof office pods and workspaces.

There were a number of other exits bringing the total for the quarter to £10.3 million. This compares with £14.1 million in Q4 2024 and £16.1 million in Q1 2024.

 

Valuation Movements

There were very few significant movements in valuation in the first quarter. Only 3.5% of the valuations were based on March 2025 marks with the remainder based on December 2024 valuations. This is not unusual as the valuation is compiled only a few weeks after the full year reports from our investments have been finalised.

There were two helpful positives from US funds Graycliff IV and Blue Point III which were up by £0.6 million and £0.4 million respectively, as a result of recent exits. On the negative side Italian focused fund Wise Equity VI was down by £0.7 million due to some pressures in the portfolio from the weaker economic background. It is still quite early in the life of the fund.

 

Financing

At 31 March 2025 the Company had net debt of £90.4 million. This is up from £76.5 million at 31 December 2024 but on a twelve-month basis is down by around £9 million. In the quarter total realisations were below the total of new investments by £5.4 million. The level of gearing at 31 March 2025 was 15.4%. The Company retains around £55 million of headroom in its borrowing facility and the current debt level is eminently manageable. The small dip in the first quarter's NAV is normal and in line with previous years.

 

Outlook

The private equity sector, in common with all other investment asset classes, has monitored the economic announcements from the US in recent weeks. Specifically attention has been paid to the proposed tariffs which have broken the long-standing paradigm that largely free trade is a desirable economic objective likely to bring increased prosperity to the greatest number of people. Apart from the adverse economic consequences, which are widely expected to follow, subsequent changes in the proposed tariffs have engendered an unusual degree of uncertainty. Even though many private equity backed companies are not directly affected by US trade tariffs, this kind of economic intervention and high level of uncertainty is not good for deal-making. Unsurprisingly we have seen some planned exits being postponed as buyers pause to consider whether the target company will be affected or not. Uncertainty also influences fund investors who are considering committing long term capital to the asset class with the current situation providing the perfect justification for holding off on new commitments. Most private equity investors are attracted to companies and sectors with clear long-term growth drivers provided that investment can be made at a price which adequately reflects the risks of the planned growth being achieved. There are likely to be changes in the value of private companies with some winners as well as losers and other factors such as flight to quality coming into play over the coming months.

Private equity is one of the most deliberative of investment management disciplines with investors not committing capital until they are in full possession of the facts and have made a full assessment of the future of a company. This research usually takes several months or even years before an investment is made. Once an investment has been made it cannot be easily reversed if the market or the economic environment changes dramatically. Private equity does however possess the ability to work with the management of investee companies to tackle any challenges and in adverse or uncertain periods the first priority of private equity managers is to support and assist their existing portfolio. Your portfolio is unusually diverse covering hundreds of companies internationally with exposure to multiple sectors and their associated economic trends and drivers. This diversification has proven to be a strength historically and it will doubtless prove to be of benefit now in protecting and building shareholder value. From here we expect that after a period of assessment the improvement in private equity activity levels which we saw during 2024 will resume.

 

 

Hamish Mair

Investment Manager

Columbia Threadneedle Investment Business Limited

 


 

 

Portfolio Summary

Portfolio Distribution at 31 March 2025

% of Total

31 March 2025

% of Total

31 December 2024

Buyout Funds - Pan European*

12.2

11.6

Buyout Funds - UK

19.5

19.2

Buyout Funds - Continental Europe†

15.3

15.5

Secondary Funds

-

-

Private Equity Funds - USA

4.6

4.4

Private Equity Funds - Global

2.6

2.7

Venture Capital Funds

4.4

4.5

Direct Investments/Co-investments

41.4

42.1


100.0

100.0

* Europe including the UK.

† Europe excluding the UK.



 

 

Ten Largest Individual Holdings

As at 31 March 2025

Total Valuation £'000

% of Total Portfolio

Inflexion Strategic Partners

19,296

3.3

Weird Fish

14,845

2.5

Sigma

12,521

2.1

August Equity Partners V

12,129

2.1

TWMA

12,087

2.1

Utimaco

10,791

1.8

San Siro

10,588

1.8

Aurora Payment Solutions

9,699

1.6

Inflexion Supplemental V

9,697

1.6

Stirling Square Capital II

9,601

1.6

121,254

20.5

 


Portfolio Holdings

Investment

Geographic

Focus

Total

Valuation

£'000

% of

Total

Portfolio

Buyout Funds - Pan European




Stirling Square Capital II

Europe

9,601

1.6

Apposite Healthcare III

Europe

9,415

1.6

F&C European Capital Partners

Europe

8,949

1.5

Apposite Healthcare II

Europe

8,457

1.4

Verdane XI

Northern Europe

3,572

0.6

Volpi III

Northern Europe

3,453

0.6

Summa III

Northern Europe

3,309

0.6

MED II

Western Europe

3,195

0.6

Agilitas 2015 Fund

Northern Europe

3,093

0.5

Magnesium Capital 1

Europe

2,512

0.4

Astorg VI

Western Europe

2,310

0.4

Wisequity VI

Italy

2,275

0.4

MED Platform II

Global

2,145

0.4

Verdane Edda III

Northern Europe

1,965

0.3

KKA II

Europe

1,858

0.3

ARCHIMED MED III

Global

1,470

0.3

Agilitas 2020 Fund

Europe

1,282

0.2

TDR Capital II

Western Europe

1,235

0.2

TDR II Annex Fund

Western Europe

1,059

0.2

Inflexion Partnership III

Europe

526

0.1

Agilitas 2024 HIF

Europe

125

-

Inflexion Enterprise Fund VI

Europe

53

-

Total Buyout Funds - Pan European


71,859

12.2





 

Buyout Funds - UK




Inflexion Strategic Partners

United Kingdom

19,296

3.3

August Equity Partners V

United Kingdom

12,129

2.1

Inflexion Supplemental V

United Kingdom

9,697

1.6

Axiom 1

United Kingdom

6,799

1.2

Inflexion Buyout Fund V

United Kingdom

6,795

1.1

Apiary Capital Partners I

United Kingdom

6,456

1.1

Inflexion Buyout Fund VI

United Kingdom

5,738

1.0

FPE Fund III

United Kingdom

5,006

0.8

FPE Fund II

United Kingdom

4,866

0.8

August Equity Partners IV

United Kingdom

4,497

0.8

Kester Capital II

United Kingdom

4,395

0.7

Corran Environmental II

United Kingdom

4,207

0.7

Inflexion Partnership Capital II

United Kingdom

4,055

0.7

Piper Private Equity VII

United Kingdom

3,922

0.7

Piper Private Equity VI

United Kingdom

3,884

0.7

Kester Capital III

United Kingdom

3,067

0.5

Inflexion Buyout Fund IV

United Kingdom

2,225

0.4

Inflexion Enterprise Fund V

United Kingdom

2,116

0.4

Inflexion Supplemental IV

United Kingdom

1,449

0.2

Inflexion Enterprise Fund IV

United Kingdom

1,434

0.2

Inflexion Partnership Capital I

United Kingdom

1,266

0.2

RJD Private Equity Fund III

United Kingdom

467

0.1

Horizon Capital 2013

United Kingdom

377

0.1

Primary Capital IV

United Kingdom

321

0.1

Piper Private Equity V

United Kingdom

163

-

August Equity Partners VI

United Kingdom

109

-

GCP Europe II

United Kingdom

91

-

Dunedin Buyout Fund II

United Kingdom

5

-

Total Buyout Funds - UK


114,832

19.5

 

 

 

 

 

 

 

 

 

 

 

 

Investment

Geographic

Focus

Total

Valuation

£'000

% of

Total   Portfolio

Buyout Funds - Continental Europe




Aliante Equity 3

Italy

8,467

1.4

Avallon MBO Fund III

Poland

6,429

1.1

DBAG VII

DACH

5,843

1.0

Bencis V

Benelux

5,296

0.9

Vaaka III

Finland

5,008

0.8

Capvis III CV

DACH

4,710

0.8

Verdane Edda

Nordic

4,509

0.8

Montefiore V

France

4,303

0.7

DBAG VIII

DACH

4,185

0.7

Corpfin V

Spain

4,136

0.7

Procuritas VII

Nordic

3,874

0.7

Procuritas VI

Nordic

3,773

0.6

Chequers Capital XVII

France

3,720

0.6

ARX CEE IV

Eastern Europe

2,980

0.5

Procuritas Capital IV

Nordic

2,595

0.4

Italian Portfolio

Italy

2,517

0.4

Vaaka IV

Finland

2,388

0.4

Aurica IV

Spain

2,138

0.4

Capvis IV

DACH

1,816

0.3

Montefiore IV

France

1,591

0.3

Summa II

Nordic

1,513

0.3

Summa I

Nordic

1,490

0.2

Corpfin Capital Fund IV

Spain

1,145

0.2

DBAG VIIB

DACH

1,074

0.2

Portobello Fund III

Spain

1,019

0.2

DBAG VIIIB

DACH

956

0.2

DBAG Fund VI

DACH

922

0.2

Chequers Capital XVI

France

629

0.1

Vaaka II

Finland

379

0.1

Ciclad 5

France

357

0.1

PineBridge New Europe II

Eastern Europe

205

-

Montefiore Expansion

France

182

-

Gilde Buyout Fund III

Benelux

99

-

Procuritas Capital V

Nordic

72

-

Capvis III

DACH

50

-

DBAG Fund V

DACH

5

-

Total Buyout Funds - Continental Europe


90,375

15.3





 




Secondary Funds




The Aurora Fund

Europe

193

-

Total Secondary Funds


193

-

 




 




 




Investment

Geographic

Focus

Total

Valuation

£'000

% of

Total

Portfolio

Private Equity Funds - USA




Blue Point Capital IV

North America

7,396

1.2

Purpose Brands (Level 5)

United States

3,477

0.6

Level 5 Fund II

United States

3,433

0.6

Camden Partners IV

United States

3,129

0.5

MidOcean VI

United States

2,190

0.4

Graycliff IV

North America

2,141

0.4

Stellex Capital Partners

North America

1,543

0.3

Blue Point Capital III

North America

1,224

0.2

Graycliff III

United States

1,032

0.2

TorQuest VI

North America

994

0.2

Blue Point Capital II

North America

157

-

Total Private Equity Funds - USA


26,716

4.6





 

 

Private Equity Funds - Global




Corsair VI

Global

8,090

1.4

Hg Saturn 3

Global

4,823

0.8

Global

1,244

0.2

Global

739

0.1

Global

398

0.1

Asia

108

-

South America

57

-

Global

10

-

Total Private Equity Funds - Global


15,469

2.6

 

 

 

Venture Capital Funds




SEP V

United Kingdom

9,022

1.5

Europe

4,896

0.8

Global

4,330

0.7

Europe

2,768

0.5

Global

1,931

0.3

United Kingdom

1,698

0.3

United Kingdom

946

0.2

United Kingdom

377

0.1

United Kingdom

59

-

Europe

57

-

Western Europe

31

-

United Kingdom

4

-

Total Venture Capital Funds


26,119

4.4

 








 

 

 

 

 

 




Investment

Geographic

Focus

Total

Valuation

£'000

% of

Total

Portfolio

Direct Investments/Co-investments




Weird Fish

United Kingdom

14,845

2.5

United States

12,521

2.1

United Kingdom

12,087

2.1

DACH

10,791

1.8

Italy

10,588

1.8

United States

9,699

1.6

Europe

9,204

1.6

United Kingdom

8,020

1.4

Netherlands

7,958

1.4

United Kingdom

7,185

1.2

North America

7,124

1.2

United Kingdom

6,853

1.2

North America

6,689

1.1

United Kingdom

6,611

1.1

Denmark

6,473

1.1

United Kingdom

6,282

1.1

United Kingdom

6,178

1.1

United Kingdom

5,996

1.0

United Kingdom

5,806

1.0

United States

5,449

0.9

United Kingdom

4,874

0.8

Canada

4,805

0.8

Canada

4,729

0.8

France

4,652

0.8

United States

4,412

0.8

Switzerland

4,163

0.7

United States

4,146

0.7

United Kingdom

4,127

0.7

United Kingdom

3,934

0.7

Canada

3,544

0.6

United Kingdom

3,452

0.6

United States

3,266

0.6

United States

3,209

0.5

Spain

3,072

0.5

Ireland

2,462

0.4

United States

2,266

0.4

United Kingdom

2,122

0.4

United Kingdom

2,039

0.3

Canada

2,022

0.3

United Kingdom

1,734

0.3

Finland

1,716

0.3

Italy

1,516

0.3

United Kingdom

1,289

0.2

United Kingdom

1,234

0.2

United States

1,175

0.2

United Kingdom

786

0.1

Bulgaria

732

0.1

Europe

277

-

Total Direct Investments/Co-investments


244,114

41.4

Total Portfolio


589,677

100.0

 

 

 

 

 

CT PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

three months ended 31 March 2025 (unaudited)

 

 


 


Revenue

£'000

Capital

£'000

Total

£'000

 

Income




Losses on investments held at fair value

-

(548)

(548)

Exchange losses

-

(1,151)

     (1,151)

Investment income

810

-

          810

Other income

108

-

           108

Total income

918

(1,699)

(781)





Expenditure




Investment management fee - basic fee

(123)

(1,103)

(1,226)

Investment management fee - performance fee

-

-

-

Other expenses

(300)

-

(300)

Total expenditure

(423)

(1,103)

(1,526)





Profit/(loss) before finance costs and taxation

495

(2,802)

(2,307)





Finance costs

(171)

(1,536)

(1,707)

 




Profit/(loss) before taxation

324

(4,338)

(4,014)





Taxation

-

-

-





Profit/(loss) for period/ total comprehensive income

324

(4,338)

(4,014)

 




Return per Ordinary Share

0.45p

(6.06)p

(5.61)p

 




 

 

 

 

 

 

 

 

 

 

 

 

 

 

CT PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

three months ended 31 March 2024 (unaudited)

 


 


Revenue

£'000

Capital

£'000

Total

£'000

 

Income




Losses on investments held at fair value

-

(5,683)

(5,683)

Exchange gains

-

1,368

       1,368

Investment income

570

-

           570

Other income

180

-

           180

Total income

750

(4,315)

(3,565)





Expenditure




Investment management fee - basic fee

(122)

(1,099)

(1,221)

Investment management fee - performance fee

-

-

-

Other expenses

(334)

-

(334)

Total expenditure

(456)

(1,099)

(1,555)





Profit/(loss) before finance costs and taxation

294

(5,414)

(5,120)





Finance costs

(218)

(1,965)

(2,183)

 




Profit/(loss) before taxation

76

(7,379)

(7,303)





Taxation

-

-

-





Profit/(loss) for period/ total comprehensive income

76

(7,379)

(7,303)

 




Return per Ordinary Share

0.10p

(10.14)p

(10.04)p

 









 

 



CT PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

year ended 31 December 2024 (audited)

 

 


 


Revenue

£'000

Capital

£'000

Total

£'000

 

Income




Gains on investments held at fair value

-

25,144

25,144

Exchange gains

-

5,055

5,055

Investment income

3,270

-

3,270

Other income

961

-

961

Total income

4,231

30,199

34,430





Expenditure




Investment management fee - basic fee

(489)

(4,404)

(4,893)

Investment management fee - performance fee

-

-

-

Other expenses

(1,226)

-

(1,226)

Total expenditure

(1,715)

(4,404)

(6,119)





Profit before finance costs and taxation

2,516

25,795

28,311





Finance costs

(864)

(7,778)

(8,642)

 




Profit before taxation

1,652

18,017

19,669





Taxation

-

-

-





Profit for year/total comprehensive income

1,652

18,017

19,669

 




Return per Ordinary Share

2.30p

25.08p

27.38p

 




 

 



CT PRIVATE EQUITY TRUST PLC

 

Balance Sheet

 

 

 

 

As at 31 March 2025

As at 31 March 2024

As at 31 December 2024

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

 £'000

Non-current assets

 

 


Investments at fair value through profit or loss

589,677

607,796

584,097

 




Current assets




Other receivables

841

3,115

1,110

Cash and cash equivalents

7,836

16,534

16,000


8,677

19,649

17,110





Current liabilities




Other payables

(4,324)

(13,129)

(3,859)

Interest-bearing bank loan

-

(65,746)

-

 

(4,324)

(78,875)

(3,859)

 




Net current assets/(liabilities)

4,353

(59,226)

13,251

 




Total assets less current liabilities

594,030

548,570

597,348

 




Non-current liabilities




Interest-bearing bank loan

(98,227)

(49,880)

(92,519)

Net assets

495,803

498,690

504,829

 




Equity




Called-up ordinary share capital

739

739

739

Share premium account

2,527

2,527

2,527

Special distributable capital reserve

3,818

9,597

3,818

Special distributable revenue reserve

31,403

31,403

31,403

Capital redemption reserve

1,335

1,335

1,335

Capital reserve

455,981

453,089

465,007

Shareholders' funds

495,803

498,690

504,829





Net asset value per Ordinary Share

693.40p

685.46p

706.03p





 



CT PRIVATE EQUITY TRUST PLC

               

Reconciliation of Movements in Shareholders' Funds

 

 

 

 

 

Three months ended

31 March

2025

Three months ended

31 March

2024

Year

ended

31 December 2024

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Opening shareholders' funds

504,829

511,093

511,093

Buyback of ordinary shares

-

-

(5,779)

(Loss)/profit for the period/total

comprehensive income

 

 (4,014)

 

 (7,303)

 

19,669

Dividends paid

(5,012)

(5,100)

(20,154)

 

Closing shareholders' funds

 

 

495,803

 

498,690

 

504,829

 

 


Notes (unaudited)

 

1.     The unaudited quarterly results have been prepared on the basis of the accounting policies set out in the statutory accounts of the Company for the year ended 31 December 2024.  Earnings for the three months to 31 March 2025 should not be taken as a guide to the results for the year to 31 December 2025.

 

2.     Investment management fee:

 

 

 

Three months ended

31 March 2025

(unaudited)

 

 

Three months ended

31 March 2024

(unaudited)

 

 

Year ended

31 December 2024

(audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Investment management       fee - basic fee

 

123

 

1,103

 

1,226

 

122

 

1,099

 

1,221

 

489

 

4,404

 

4,893

Investment management       fee - performance fee

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

 

123

 

1,103

 

1,226

 

122

 

1,099

 

1,221

 

489

 

4,404

 

4,893

 

 

 

 

 

 

 

 

 

 

 

3.     Finance costs:

 

 

 

Three months ended

31 March 2025

(unaudited)

 

 

Three months ended

31 March 2024

(unaudited)

 

 

Year ended

31 December 2024

(audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Interest payable on bank loans

171

1,536

1,707

218

1,965

2,183

864

7,778

8,642

 

 

 

 

 

 

 

 

 

 

 

4.     Returns and net asset values

 

Three months ended

31 March 2025

(unaudited)

Three months ended

31 March 2024

(unaudited)

Year ended

31 December 2024

(audited)

The returns and net asset values per share are based on the following figures:

 

 

 

 

Revenue Return

£324,000

£76,000

£1,652,000

Capital Return

(£4,338,000)

(£7,379,000)

£18,017,000

Net assets attributable to shareholders

£495,803,000

£498,690,000

£504,829,000

Number of shares in issue at the period end

71,502,938

72,752,938

71,502,938

Weighted average number of shares in issue during the period

71,502,938

72,752,938

71,845,834

 

 

 

5.     The financial information for the three months ended 31 March 2025, which has not been audited or reviewed by the Company's auditor, comprises non-statutory accounts within the meaning of Section 434 of the Companies Act 2006.  Statutory accounts for the year ended 31 December 2024, on which the auditor issued an unqualified report, will be lodged shortly with the Registrar of Companies.  The quarterly report will be available shortly on the Company's website www.ctprivateequitytrust.com

 

 

Legal Entity Identifier: 2138009FW98WZFCGRN66

 

For more information, please contact:

 

Hamish Mair (Investment Manager)

0131 573 8314

Scott McEllen (Company Secretary)

0131 573 8372

hamish.mair@columbiathreadneedle.com  / scott.mcellen@columbiathreadneedle.com


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFPKCBQKBKDCPB